Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination


Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site. (US Food Recalls) More More

Similar stories

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination - Pharmacy Times

Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination  Pharmacy Times

Novartis has issued a voluntary recall of 3 lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level, due to a risk of potential peanut ...

Posted on 13 May 2019 | 2:00 am | Google News

BRIEF-Novartis AG Issues Voluntary Nationwide Recall Of Promacta 12.5 Mg For Oral Suspension Due To Potential Peanut Contamination - Reuters

BRIEF-Novartis AG Issues Voluntary Nationwide Recall Of Promacta 12.5 Mg For Oral Suspension Due To Potential Peanut Contamination  Reuters

May 11 (Reuters) - Novartis AG: * ISSUES VOLUNTARY NATIONWIDE RECALL OF PROMACTA® 12.5 MG FOR ORAL SUSPENSION DUE TO POTENTIAL ...

Posted on 11 May 2019 | 4:50 pm | Google News

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination - FDA.gov

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension Due to Potential Peanut Contamination  FDA.gov

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...

Posted on 11 May 2019 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info